TWST - Why Synthetic DNA Company Twist Bioscience Shares Are Jumping Today | Benzinga
Twist Bioscience Corp's (NASDAQ: TWST) Q4 sales increased 16.8% Y/Y to $66.9 million, beating the consensus of $63.45 million.
The company's Q4 revenue exceeded the management guidance of $63 million-$64 million.
The company reported a Q3 EPS loss of $(0.81), better than the consensus of $(0.92).
Total orders received for the fourth quarter of fiscal 2023 grew to ...